Close



Sep 25, 2023 08:35AM
Sep 25, 2023 08:34AM
Aug 9, 2023 07:32AM
Aug 9, 2023 07:30AM
May 4, 2023 06:30AM
Mar 24, 2023 08:49AM
Feb 3, 2023 06:30AM Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Nov 3, 2022 06:30AM
Sep 16, 2022 07:16AM
Sep 16, 2022 07:15AM
Sep 16, 2022 07:15AM
Aug 4, 2022 10:21AM
Aug 3, 2022 06:30AM
Jul 1, 2022 07:00AM Regeneron Completes Purchase of Sanofi's Stake in Libtayo® (cemiplimab)
Jun 2, 2022 07:31AM
Jun 2, 2022 07:30AM
Jun 2, 2022 01:00AM
May 31, 2022 08:36AM
May 31, 2022 08:31AM
May 4, 2022 06:30AM
Apr 19, 2022 12:59PM CHECKMATE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CMPI and Encourages Investors to Contact the Firm
Apr 19, 2022 09:24AM
Apr 19, 2022 08:48AM
Apr 19, 2022 07:58AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
Aug 6, 2021 09:22AM
Aug 5, 2021 06:19PM
May 6, 2021 06:30AM
Feb 11, 2021 02:01PM
Feb 11, 2021 02:00PM
Feb 5, 2021 06:30AM
Jan 12, 2021 05:45PM Regeneron (REGN) Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
Jan 12, 2021 05:45PM
Oct 9, 2020 04:50PM
Oct 5, 2020 09:30AM
Jun 23, 2020 07:10AM
Nov 24, 2019 04:00PM
Jun 26, 2019 01:30PM
Jun 26, 2019 01:30PM FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis
Jun 26, 2019 01:30PM
Jun 26, 2019 01:29PM
Feb 25, 2019 04:58PM
Dec 14, 2018 09:31AM
Oct 22, 2018 07:03AM
Oct 22, 2018 07:00AM
Oct 22, 2018 06:06AM Regeneron (REGN), Sanofi (SNY) Report FDA Approval of Asthma Indication for Dupixent (dupilumab)
Oct 19, 2018 05:59PM

887,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All